Idexx Laboratories IDXX Rebate and up-front considerations arrangements — Deferred Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue?
- Idexx Laboratories (IDXX) reported rebate and up-front considerations arrangements — deferred revenue of $35.5M in Q1 2026.
- How has Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue changed year-over-year?
- Idexx Laboratories's rebate and up-front considerations arrangements — deferred revenue increased by 18.3% year-over-year, from $30M to $35.5M.
- What does rebate and up-front considerations arrangements — deferred revenue mean?
- This metric quantifies the total amount of consideration received from customers for rebate and up-front arrangements that has not yet been recognized as revenue. It reflects the liability the company carries for services or products promised but not yet delivered under these specific commercial contracts. This balance is a key indicator of future revenue potential tied to existing customer agreements.